课题基金 / 基金详情

ARGINASE & NO SYNTHASE & ACTIVITY IN SKIN: EFFECTS OF ESSENTIAL HYPERTENS & AGE

ARGINASE & NO SYNTHASE & ACTIVITY IN SKIN: EFFECTS OF ESSENTIAL HYPERTENS & AGE
精氨酸酶
批准号:
7625850
负责人:
LACY HOLOWATZ
金额:
$0.11万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2008-03-31

项目摘要

项目成果

LACY HOLOWATZ的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 高血压血管疾病(HT)的特征是神经递质信号改变,导致皮肤和其他器官的血管扩张受损。羟色胺引起一氧化氮(NO)可获得性的变化,从而导致血管扩张减少。在皮肤中,NO是一种关键的信号分子,参与血管张力和对热刺激的反应。羟色胺可通过1)提高精氨酸酶活性和2)降低一氧化氮合酶活性来减少NO的产生。人类皮肤中精氨酸酶和一氧化氮合酶活性的变化还没有被探索过。我们建议用蛋白质印迹分析和免疫组织化学方法检测皮肤穿孔活检组织中精氨酸酶和一氧化氮合酶的活性。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Hypertensive vascular disease (HT) is characterized by alterations in neurotransmitter signals leading to impaired dilation of blood vessels in skin and other organs. HT causes changes in nitric oxide (NO) availability that lead to reduced vasodilation of blood vessels. In the skin, NO is a key signaling molecule involved in vascular tone and responses to thermal stimuli. HT can decrease NO production by 1) increased arginase activity and 2) decreased NO-synthase activity. Changes in arginase and NO-synthase activity in human skin have not been explored. We propose to examine arginase and NO-synthase activity in skin punch biopsies using Western blot analysis and immunohistochemistry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ARGINASE & NO SYNTHASE & ACTIVITY IN SKIN: EFFECTS OF ESSENTIAL HYPERTENS & AGE
HYPERCHOLESTEROLEMIA AND HUMAN SKIN BLOOD FLOW
PLATELET INVOLVEMENT IN REFLEX CUTANEOUS VASODILATION
MECHANISMS OF NO-CONTRIBUTION TO REFLEX CUTANEOUS VASODILATION WITH HYPERTENSIO
海外基金